CompletedNCT02371889
Topiramate and Genetic Factors in Heavy Drinking
About this title
Read the official source — NCT02371889Medication studyAges 18–70United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 70 years.
- Listed locations
- Philadelphia and 1 more locationSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: December 18, 2014
- Recruitment status
- Completed
- Enrollment listed in the registry
- 320
- Sponsor
- University of Pennsylvania
- Sponsor type
- University
- Study type
- Behavioral
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT02371889
- Official title
Show the full official title
A Randomized, Double-blind Placebo-Controlled Pharmacogenetic Study of Topiramate in European-American Heavy Drinkers
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Philadelphia
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Pennsylvania, a university.
Did this study involve medication?
Yes. The study involved medication, including Topiramate and Inactive Placebo.
Who was this study for?
Listed age limits: 18 years to 70 years.
